Table 7.
Haematological evaluation of GTN-treated sub-acute toxicity.
| Control | GTN-treated | |
|---|---|---|
| Creatinine (µmol/L) | 25.22 ± 1.13 | 26.24 ± 1.14 |
| Urea (mmol/L) | 5.95 ± 0.33 | 5.85 ± 0.15 |
| Albumin (g/L) | 35.9 ± 3.2 | 33.2 ± 4.3 |
| Globulin (g/L) | 23.2 ± 2.8 | 21.3 ± 3.9 |
| Total bilirubin (µmol/L) | 2.0 ± 0.8 | 2.1 ± 0.9 |
| Alkaline phosphatase (U/L) | 13.9 ± 1.1 | 14.2 ± 0.5 |
| Alanine aminotransferase (U/L) | 118 ± 31 | 115 ± 12 |
| Aspartate aminotransferase (U/L) | 99.5 ± 5.6 | 100 ± 7.1 |
The results are expressed as the mean ± Standard error, (n=7). No significant difference could be detected between the GTN-treated group vs the control group. Control, the normal control group; GTN-treated, 42 mg/kg intraperitoneal GTN-treated group.